FFLS ETF Analysis

이 페이지는 영어 원문에서 AI로 기계 번역되었습니다. 영어 버전이 기준입니다. 영어 버전 읽기

정보 제공만을 목적으로 합니다. 재정적 조언이 아닙니다.

빠른 답변

FFLS ETF has a last stored price of $22.96, as of the Oct 23, 2026 trading session. Holdings and weights below are as of Mar 15, 2026.

In the stored portfolio snapshot, the largest listed holding is NVIDIA Corp (NVDA) at 3.78%.

FFLS ETF — Price, Holdings & Analysis

ETF 개요

FFLS provides exposure to a select group of companies. The ETF's top allocations include technology giant NVIDIA Corp, medical technology company Edwards Lifesciences Corp, and Alphabet Inc Class A. Other notable holdings include Corning Inc, Safran SA ADR, and Halozyme Therapeutics Inc. This concentrated approach means that the performance of FFLS is heavily influenced by the performance of these key holdings. Investors seeking a focused approach may find FFLS appealing, while those preferring broader diversification may consider other options. Past performance does not guarantee future results.

위험 지표

FFLS carries a high degree of concentration risk due to its limited number of holdings. A significant downturn in any of its top holdings, such as NVIDIA Corp or Edwards Lifesciences Corp, could have a substantial negative impact on the ETF's overall return. The fund's beta is 0.00. Investors should carefully consider their risk tolerance and investment objectives before investing in FFLS. Past performance does not guarantee future results.

베타: 0.00

FFLS은(는) 무엇을 보유하고 있나요?

보유 종목	비중
NVIDIA Corp (NVDA)	3.78%
Edwards Lifesciences Corp (EW)	3.76%
Alphabet Inc Class A (GOOGL)	3.67%
Corning Inc (GLW)	3.58%
Safran SA ADR (SAFRY)	3.47%
Halozyme Therapeutics Inc (HALO)	3.26%
Equinix Inc (EQIX)	3.16%
Quanta Services Inc (PWR)	3.13%
Amazon.com Inc (AMZN)	2.92%
TechnipFMC PLC (FTI)	2.86%

보유 종목 및 비중: 2026년 3월 15일 기준. 이 펀드 데이터는 45일 이상 지났습니다. 최신 보유 종목은 발행사에서 확인하세요.

배당수익률

0.00%

질문 및 답변

What is FFLS and what does it track?

The fund's strategy results in significant allocations to individual companies. As of 2026-03-15, the top holdings include NVIDIA Corp, Edwards Lifesciences Corp, and Alphabet Inc Class A.

This concentrated approach means that the ETF's performance is heavily influenced by the performance of these key holdings. Investors should carefully review the fund's holdings and strategy before investing. Past performance does not guarantee future results.

What are the top holdings in FFLS?

As of 2026-03-15, the top holdings in FFLS are: NVIDIA Corp (3.78%), Edwards Lifesciences Corp (3.76%), Alphabet Inc Class A (3.67%), Corning Inc (3.58%), and Safran SA ADR (3.47%).

These five companies account for a significant portion of the ETF's total assets.

Is FFLS a good long-term investment?

FFLS's suitability as a long-term investment depends on an individual investor's risk tolerance and investment objectives. The ETF's concentrated portfolio introduces a higher degree of risk compared to more diversified ETFs.

Investors should carefully consider the fund's holdings, strategy, and risk profile before making any investment decisions. The fund's dividend yield is 0.00%. Past performance does not guarantee future results.

How does FFLS compare to similar ETFs?

FFLS distinguishes itself through its highly. This contrasts with many ETFs that hold a much larger number of stocks to achieve broader diversification. Investors should also consider the fund's investment strategy and risk profile when comparing it to other ETFs.

Past performance does not guarantee future results.

Does FFLS pay dividends?

As of 2026-03-15, FFLS has a dividend yield of 0.00%. This indicates that the fund does not currently distribute dividends to its shareholders. Investors seeking income-generating investments may want to consider other ETFs with a higher dividend yield.

It's important to note that dividend yields can fluctuate over time. Past performance does not guarantee future results.

면책 조항: 이 콘텐츠는 정보 제공만을 목적으로 하며 투자 조언을 구성하지 않습니다. 항상 자체 조사를 수행하고 재정 고문과 상담하십시오.

데이터는 정보 제공만을 목적으로 제공됩니다.

이 페이지는 기계가 작성했으며, 페이지별 사람 검수는 거치지 않았습니다. 편집 관리는 체계 차원에서 이루어집니다: 규칙과 출처를 점검하며, 개별 페이지는 점검하지 않습니다.